Prostate Cancer

Long-term trends in the burden of prostate cancer in the United States from 1990 to 2021: A detailed analysis based on the Global Burden of Disease Study 2021. June 30, 2026

Radioligand Therapy for Prostate Cancer - A Clinical Consultation Guide. June 30, 2026

Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies. June 30, 2026

Contemporary Prostate Cancer Intraprostatic Imaging Scores: A Practical and Hands-on Guide for Urologists. June 29, 2026

First Results Comparing MLC Versus IRIS CyberKnife Collimators in Prostate Stereotactic Body Radiation Therapy in an Italian Oncology Institute. June 29, 2026

A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413. June 29, 2026

Optimal MRI sequence for predicting extraprostatic extension in prostate cancer: comparison of LCC and MaxRADD measurements. June 26, 2026

Integrative genomic profiling of newly diagnosed prostate cancers progressing on surveillance. June 26, 2026

Incidence and Short- to Intermediate-Term Oncological Outcomes of Pathological T0 Prostate Cancer After Robot-Assisted Radical Prostatectomy: A Multicenter, Retrospective Cohort Study in Japan (MSUG94 Group). June 26, 2026

Quantifying the Renal Impact of [177Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry - Beyond the Abstract June 25, 2026

Deep learning classification of significant prostate cancer on MRI: a systematic review and meta-analysis. June 30, 2026

Cancer-specific mortality of grade group 1 prostate cancer: Results from Surveillance, Epidemiology, and End Results Database, 2004-2021. June 30, 2026

Treatment Patterns and Attrition in Metastatic Castration-Resistant Prostate Cancer. June 30, 2026

Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer. June 29, 2026

Evolving Systemic Therapy for Prostate Cancer: Pivotal Clinical Trials, Biomarker-Driven Combinations, and Practical Sequencing in the ARSI-PARP-Radioligand Era. June 29, 2026

Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy. June 29, 2026

The Effect of Prostate Volume and 5-Alpha Reductase Inhibitor Use on Grade Progression and Treatment Decisions in Patients with Prostate Cancer on Active Surveillance. June 26, 2026

Development and validation of a multimodal artificial intelligence-based model for predicting post-prostatectomy treatment outcomes from baseline biparametric prostate magnetic resonance imaging. June 26, 2026

Post-diagnosis physical activity in relation to mortality among prostate cancer survivors: a systematic review and meta-analysis. June 26, 2026

PANDA-PLUS: Improved Dataset of Prostate Whole Slide Images from PANDA Challenge with Pixel-Level Expert Annotations - Beyond the Abstract June 25, 2026

Page 1 of 1640